Thank you for choosing to subscribe to the eTOC for Anti-Cancer Drugs

Enter your Email address:

Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy.

Anti-Cancer Drugs

Wolters Kluwer Health Logo

Login
Register
Activate Subscription
Subscribe
eTOC
Help

Advanced Search
Saved Searches
Recent Searches

You currently have no recent searches

Home	Current Issue	Previous Issues	Published Ahead-of-Print	For Authors	Journal Info

About the Journal

Editorial Board

Advertising

Subscription Services

Reprints

Job Opportunities

Rights and Permissions

Mobile

New Features

Editor-in-Chief:	Mels Sluyser, PhD
ISSN:	0959-4973
Online ISSN:	1473-5741
Frequency:	10 / year
Ranking:	89 of 165 Oncology, 123 of 236 Pharmacology & Pharmacy
Impact Factor:	2.230

Current Issue: September 2010 - Volume 21 - Issue 8

Subscribe to eTOC

Add Item(s) to:

An Existing Folder

A New Folder

Folder Name:

Description:

The item(s) has been successfully added to "".

Email to a Colleague

Colleague's E-mail is Invalid

Your Name: (optional)

Your Email:

Colleague's Email:

Separate multiple e-mails with a (;).

Message:
Thought you might appreciate this item(s) I saw at Anti-Cancer Drugs.

Send a copy to your email

Your message has been successfully sent to your colleague.

Some error has occurred while processing your request. Please try after some time.

Export to.

End Note
Procite
Reference Manager

Save my selection

Current Issue Highlights

Select All | Hide Details

Review Articles

MDA-7/IL-24 as a cancer therapeutic: from bench to bedside

Dent, Paul; Yacoub, Adly; Hamed, Hossein A.; Park, Margaret A.; Dash, Rupesh; Bhutia, Sujit K.; Sarkar, Devanand; Gupta, Pankaj; Emdad, Luni; Lebedeva, Irina V.; Sauane, Moira; Su, Zhao-Zhong; Rahmani, Mohamed; Broaddus, William C.; Young, Harold F.; Lesniak, Maciej; Grant, Steven; Curiel, David T.; Fisher, Paul B.

Anti-Cancer Drugs. 21(8):725-731, September 2010.

doi: 10.1097/CAD.0b013e32833cfbe1

Purchase Access

+ Favorites

EPUB EPUB

PDF (158 KB)

Abstract

Abstract:

Preclinical Reports

Chimeric tyrosine kinase-HDAC inhibitors as antiproliferative agents

Uecker, Andrea; Sicker, Marit; Beckers, Thomas; Mahboobi, Siavosh; Hägerstrand, Daniel; Östman, Arne; Böhmer, Frank-D.

Anti-Cancer Drugs. 21(8):759-765, September 2010.

doi: 10.1097/CAD.0b013e32833ccf25

Purchase Access

+ Favorites

EPUB EPUB

PDF (251 KB)

Abstract

Abstract:

Clinical Reports

A phase I/II and pharmacogenomic study of pemetrexed and cisplatin in patients with unresectable, advanced gastric carcinoma

Chen, Jen-Shi; Chao, Yee; Bang, Yung-Jue; Roca, Enrique; Chung, Hyun C.; Palazzo, Felipe; Kim, Yeul H.; Myrand, Scott P.; Mullaney, Brian P.; Shen, Li J.; Linn, Carlos

Anti-Cancer Drugs. 21(8):777-784, September 2010.

doi: 10.1097/CAD.0b013e32833cfbca

Purchase Access

+ Favorites

EPUB EPUB

PDF (149 KB)

Abstract

Abstract:

Case Reports

Successful dexrazoxane treatment of a potentially severe extravasation of concentrated doxorubicin

Conde-Estévez, David; Saumell, Silvia; Salar, Antonio; Mateu-de Antonio, Javier

Anti-Cancer Drugs. 21(8):790-794, September 2010.

doi: 10.1097/CAD.0b013e32833d9032

Purchase Access

+ Favorites

EPUB EPUB

PDF (129 KB)

Abstract

Abstract:

Table of Contents Sections

Review Articles
Preclinical Reports
Clinical Reports
Case Reports

Select All

NEW! Articles on your eReader

Username or Email:

Password:

Remember me

Forgot Password?

Need to Activate a New Subscription?
Recently purchased a subscription? Login or Register a new account and enter your subscription ID, or Subscribe Now!

Forgot your Password?

Enter and submit the email address you registered with. An email with instructions to reset your password will be sent to that address.

Email:

Forgot your Password?

Link to reset your password has been sent to specified email address.

Remember me

What does "Remember me" mean?
By checking this box, you'll stay logged in for 14 days or until you logout. You'll get easier access to your articles, collections, media, and all your other content, even if you close your browser or shut down your computer.

To protect your most sensitive data and activities (like changing your password), we'll ask you to re-enter your password when you access these services.

What if I'm on a computer that I share with others?
If you're using a public computer or you share this computer with others, we recommend that you uncheck the "Remember me" box.